Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Syndrome X

E Ferrannini1

  • 1CNR Institute of Clinical Physiology, University of Pisa, Italy.

Hormone Research
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Syndrome X, characterized by hyperinsulinaemia and metabolic changes, is a key risk factor for cardiovascular disease. It interacts with genetic and environmental factors, contributing to the development of heart disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.

Diabetes & metabolism·2021
Same author

Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man.

Metabolism: clinical and experimental·2019
Same author

Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
Same author

Obesity and carotid artery remodeling.

Nutrition & diabetes·2015
Same author

The amino acid response to a mixed meal in patients with type 2 diabetes: effect of sitagliptin treatment.

Diabetes, obesity & metabolism·2014
Same author

Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine.

La Clinica terapeutica·2014
Same journal

Abstracts of the LWPES/ESPE 8th Joint Meeting Global Care in Paediatric Endocrinology, in collaboration with APEG, APPES, JSPE and SLEP. New York City, New York, USA. September 9-12, 2009.

Hormone research·2011
Same journal

Abstracts of the 47th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Istanbul, Turkey. September 20-23, 2008.

Hormone research·2011
Same journal

Abstracts of the 46th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Helsinki, Finland. June 27-30, 2007.

Hormone research·2011
Same journal

Genetic and pathogenetic aspects of Noonan syndrome and related disorders.

Hormone research·2009
Same journal

Response to growth hormone in short children with Noonan syndrome: correlation to genotype.

Hormone research·2009
Same journal

Growth hormone and the heart in Noonan syndrome.

Hormone research·2009
See all related articles

Area of Science:

  • Cardiovascular Science
  • Metabolic Syndrome Research
  • Epidemiology

Background:

  • Syndrome X, also known as primary insulin resistance syndrome, is a complex condition.
  • Understanding its components and impact on cardiovascular health is crucial.

Purpose of the Study:

  • To redefine Syndrome X based on specific metabolic and physiological markers.
  • To establish Syndrome X as an independent atherogenic cardiovascular risk factor.

Main Methods:

  • Cross-sectional and longitudinal data analysis from the San Antonio Heart Study.
  • Evaluation of hyperinsulinaemia, glucose tolerance, lipid profile, blood pressure, and body fat distribution.

Main Results:

  • Syndrome X redefined by hyperinsulinaemia, altered glucose tolerance, lipid patterns, blood pressure, and body fat distribution.

Related Experiment Videos

  • Syndrome X identified as an atherogenic cardiovascular risk factor.

    • Conclusions:

    • Syndrome X is a significant risk factor for cardiovascular disease.
    • Interactions between environmental and genetic factors exacerbate cardiovascular disease risk in Syndrome X.